The 2024 MM+M Awards winners; Pfizer announces a combination of its drugs prolonged the lives of patients with a type of advanced prostate cancer; Gritstone Bio files for Chapter 11 bankruptcy.
Activist investor claims Pfizer coerced former execs amid power struggle
GSK spends $2.2 billion to settle lawsuits over heartburn medication Zantac causing cancer; Illumina rolls out cheaper, smaller versions of gene sequencers; GLP-1s could cost Medicare $35 billion over eight years.
Five things for pharma marketers to know for Wednesday morning
GSK, Pfizer RSV vaccine sales fall in U.S.; Vice President Kamala Harris proposes a new Medicare benefit for in-home eldercare; Former President Donald Trump secretly sent rare COVID tests from to Russian President Vladimir Putin.
Skyrizi notches top pharma, Rx brand spot for Q3 2024
Citing people familiar with the matter, The Journal reported that Starboard approached former Pfizer CEO Ian Read and CFO Frank D’Amelio to assist in its plans.
Five things for pharma marketers to know for Monday morning